Bill & Melinda Gates Foundation

Latest statistics and disclosures from Bill & Melinda Gates Foundation's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are VIR, CVAC, BNTX, IMCR, EXAI, and represent 95.31% of Bill & Melinda Gates Foundation's stock portfolio.
  • Reduced shares in these 2 stocks: LMDX (-$33M), SERA.
  • Sold out of its positions in SERA, LMDX.
  • Bill & Melinda Gates Foundation was a net seller of stock by $-36M.
  • Bill & Melinda Gates Foundation has $130M in assets under management (AUM), dropping by -30.05%.
  • Central Index Key (CIK): 0001663801

Tip: Access up to 7 years of quarterly data

Positions held by Bill & Melinda Gates Foundation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Bill & Melinda Gates Foundation

Bill & Melinda Gates Foundation holds 9 positions in its portfolio as reported in the June 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Vir Biotechnology (VIR) 30.5 $40M 1.6M 25.46
Curevac N V (CVAC) 17.9 $23M 1.7M 13.63
Biontech Se Sponsored Ads (BNTX) 17.1 $22M 149k 149.32
Immuncore Hldgs Ads (IMCR) 16.5 $22M 577k 37.27
Exscientia Ads (EXAI) 13.3 $17M 1.6M 10.87
Butterfly Network Cl A Com (BFLY) 2.4 $3.1M 1.0M 3.07
Atreca Cl A Com (BCEL) 1.8 $2.4M 1.3M 1.80
Amyris Com New (AMRS) 0.4 $500k 292k 1.71
Zymergen (ZY) 0.1 $100k 60k 1.67

Past Filings by Bill & Melinda Gates Foundation

SEC 13F filings are viewable for Bill & Melinda Gates Foundation going back to 2020